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1. Introduction 
The adrenomedullary catecholamines are stored 
within special cytoplasmic particles, chromaffin gran- 
ules (CC), together with ATP, phospholipids and sol- 
uble acidic protein [I] . The soluble protein [2] and its 
main component, chromogranin A [3,4] are unusually 
rich in acidic amino acids, notably glutamic acid, and 
proline, but poor in cystine. CC share a number of 
structural and cytochemical features with lysosomes, 
including a selective staining by basic dyes in viva and 
supra vitum [S-8]. Since the vital basophilia of lyso- 
somal particles is due to the presence of an acidic lipo- 
protein (LP) [9], we have searched for a similar con- 
stituent in CC. Helle in a brief abstract [lo] reported 
that protein in crude lysates of CC is associated with 
a small amount of phospholipid and exhibits a buoyant 
density of about 1.34 g/ml, and suggested that chromo- 
granin may be a high density LP. We now confirm Hel- 
le’s findings. We show further that the soluble fraction 
of CC contains a number of acidic LPs which differ in 
buoyant densities, lipid composition, and electrophoret- 
ic mobilities on polyacrylamide gels. These LPs seem 
to comprise the bulk of the soluble proteins or “chro- 
mogranins” [ 111 . 
2. Materials and methods 
CC were prepared from fresh bovine adrenal medulla 
by differential and density gradient centrifugation [ 121. 
The pellet, approximately 120- 130 mg protein per ex- 
periment, was suspended in 10 ml of 0.2% Triton X-l 00 
with 1 mM EDTA pH 7.2 and sonicated in a Branson 
North-Holland Publishing Company-Amsterdam 
Model W185D Sonifier for 10 min (in one min burst 
alternating with one min rest periods). In two exper- 
iments Triton X-100 was omitted from the extraction 
medium. The insoluble residue was sedimented by 
ultracentrifugation for 30 min in a no. 50 Spinco 
Rotor. Lipoproteins were fractionated by ultracentri- 
fugal flotation in KBr solutions as described earlier 
[9]. The soluble fraction was adjusted to a specific 
gravity of 1.2 I g/ml by adding solid KBr and centri- 
fuged for 16 hr at 37,000 rpm in a no. 50 Spinco 
Rotor. An opaque yellowish surface layer, approxi- 
mately 1 ml, designated the low density LP fraction 
(LDLP) was removed. The specific gravity of the sub- 
natant was raised to 1.35 g/ml by further addition 
of KBr, recentrifuged for 16 hr at 37,000 rpm, and 
a second floating layer of one ml. the high density LP 
fraction (HDLP). separated from the subnatant. the 
very high density LP fraction (VHDLP). The three 
LP fractions were dialyzed against 1 mM EDTA pH 
7.2 to remove KBr. All procedures were carried out 
at 4”. The several fractions were analyzed for protein 
[ 131 , lipid phosphorus [ 141 , and cholesterol [ 151. 
The phospholipid composition of lipid extracts [ 161 
was determined by thin layer chromatography as de- 
scribed earlier [9]. The amino acid composition of 
protein hydrolysates (6 N HCl. 1 1 O”, 48 hr) was de- 
termined in an automatic amino acid analyzer. Disc 
get etectrophoresis [171 was carried out in 7.5% acryl- 
amide gels at pH 8.8. Protein bands in gels were 
stained with Amido schwarz (1% in 7% acetic acid), 
phospholipid with Sudan black B or acridine orange 
(0.05% in 0.01 M glycine buffer pH 7.5 with 2% HCHO). 
121 
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Composition of lipoprotein fraction from bovine chromaffin granules*. 
Protein Phospholipids Cholesterol moles Cholesterol 
% of total % of total mg/mg protein % of total mg/mg protein moles Phospholipid 
Soluble Fraction 67.56 f 2.77 82.47 f 4.85 0.42 + 0.05 79.93 _ - 
LDLP (d<1.21) 14.08 + 0.46 43.80 + 2.42 1.27 f 0.20 54.10 0.50 0.81 
HDLP (d=1.21-1.35) 29.52 * 2.80 31.15 kO.63 0.45 + 0.11 33.50 0.16 0.68 
VHDLP (d>1.35) 56.40 + 3.2 25.05 * 2.48 0.18 f 0.04 12.4 0.03 0.33 
% Recovery 59.20 f 5.67 55.19 k4.25 - - - - 
Residue 32.34 + 2.75 17.55 +_ 4.86 0.19 f 0.01 20.07 0.04 0.35 
* Mean k standard error. Protein and phospholid values are based on three separate experiments. Cholesterol values are the mean 
of two experiments. 
Table 2 
Phospholipid composition of lipoprotein fractions from bovine 
chromaffin granules. 
% of Total Phospholipid 
LDLP HDLP VHDLP 
Phosphatidyl serine 8.2 11.0 8.9 
Lysolecithin 9.2 8.8 15.1 
Sphingomyelin 16.3 13.0 18.3 
Lecithin 30.4 30.6 10.7 
Phosphatidyl 
ethanolamine 23.7 21.9 24.2 
Cardiolipin 12.2 14.7 22.8 
The values for LDLP and HDLP are means of two experiments; 
the VHDLP is based on one experiment. 
3. Results and discussion 
On electron microscopic examination the pellets 
consisted almost exclusively of typical chromaffin gran- 
ules with rare contaminating mitochondria, lysosomes or 
other structures. About 68% of the protein and 82% of 
the phospholipid of the granular fraction was solubilized 
by sonication in 0.2% Triton X-100 (table 1). The sol- 
uble fraction was subdivided by ultracentrifugal flota- 
tion into three LP fractions: a low density LP (LDLP, 
d< 1.2 1 g/ml), 14%, a high density LP (HDLP, d = 
1.2 1- 1.35 g/ml), 30%, and F very high density LP 
(VHDLP, d> 1.35 g/ml), 56% of the total soluble pro- 
tein. The phospholipid and cholesterol content of these 
LPs varied inversely with their buoyant density, 
ranging from 1.27 mg phospholipid and 0.5 mg choles- 
terol per mg protein for the LDLP to 0.18 mg phos- 
122 
pholipid and 0.03 mg cholesterol per mg protein for 
the VHDLP. The molar ratio of cholesterol to phos- 
pholipid decreased from 0.81 for the LDLP to 0.33 
for the VHDLP. Blaschko et al. [ 181 reported a molar 
ratio of cholesterol to phospholipid of 0.7 for whole 
chromaffin granules. The residue, 32% of the total 
granule protein, contained considerable phospholipid, 
0.19 mg, and cholesterol, 0.04 mg, per mg protein, 
and may include the insoluble LP which seems to orig- 
inate from the membranous envelope of the CC (see 
below). 
The phospholipid composition of the three LP frac- 
tions was similar (table 2). The relatively high lysol- 
ecithin content of the CC (18-20) was reflected in 
similar high values for this phospholipid in the LP frac- 
tions. The acidic phospholipids, phosphatidyl serine 
and cardiolipin, comprised a relatively large portion, 
15-3 l%, of the total phospholipids. The amino acid 
composition of the TCA- and lipid-extracted fractions 
(table 3) differed only in minor details from one another 
and closely resembled that of the total soluble protein 
of CC [2] and of chromogranin A [3,4] in its high 
glutamic acid and proline and low cystine content. 
The soluble extract and the three LP fractions were 
analyzed by disc electrophoresis (fig. 1). Approximate- 
ly 9 protein bands were resolved in the soluble extract. 
The same 9 protein components were observed in the 
three LP fractions with but minor quantitative variations. 
However a slowly moving protein, band 8, present in 
trace amounts in the LDLP and VHDLP, was a major 
component of the HDLP. All major protein bands and 
most of the minor components, as nearly as could be 
ascertained, were stained by Sudan black B, thereby 
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Table 3 
Amino acid composition of lipoprotein fractions from bovine chromaffin granules. 
Comparison with soluble protein and chromogranin A 
Lysine 
Histidine 
Arginine 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Prohne 
Glycine 
Alanine 
Half cystine 
Valine 
Methionine 
fsoleucine 
Leucine 
Tyrosine 
Phenylalanine 
LDLP HDLP VHDLP SoLprotein Chromogranin A 
93.7 61.8 69.6 72.6 82.6 
23.2 24.2 28.3 21.4 18.8 
50.6 58.8 71.8 68.4 60.9 
81.2 107.1 92.3 81.2 81.2 
31.9 34.4 36.6 30.0 27.5 
59.6 58.0 63.4 16.9 19.7 
185.8 275.3 200.6 222.2 226.0 
65.0 48.4 80.7 89.7 98.7 
73.0 64.4 80.3 85.5 75.4 
79.4 67.2 80.9 85.5 79.8 
14.2 0 7.1 0 4.4 
51.0 51.2 46.6 38.5 36.2 
7.0 3.1 1.5 12.8 18.8 
29.9 27.6 24.0 12.8 10.1 
104.0 19.8 76.2 12.6 12.5 
21.1 10.9 16.5 12.8 11.6 
29.4 21.6 23.6 17.1 15.9 
Lipoprotein fractions were precipitated with 10% trichioroaceti~ acid lipids extracted with chloroform-n~ethanol(2: 1, v/v), and 
the residual protein hydrolyzed in 6 N HCl at 110’ for 72 hr, and analyzed in an automatic amino acid analyzer. Results are given 
as amino acid residues per 1000. The values for LDLP and HDLP are the mean of two experiments, and for VHDLP, one experi- 
ment. Soluble protein values calculated from Heile [ 21. Chromogranin A values calculated from Smith and Winkier [ 3] . 
demonstrating that the phospholipids in the LP frac- 
tions were indeed associated with proteins. The var- 
ious LP bands also stained metachromatically with the 
basic fluorochrome acridine orange, indicating the pres- 
ence of anionic groups. 
In two experiments the CG were lysed by suspend- 
ing in 1 mM EDTA pH 7.2 at 4” without Triton X-100 
or sonication, and the insoluble residue removed by 
ultracentrifugation. Electron microscopic examination 
showed that the majority of CC were disrupted, mem- 
brane profiles with little or no granular contents making 
up the bulk of the pellet. Chemical analysis revealed that 
4065% of the protein and 30-61.8% of the phospho- 
lipid of the CG was present in the soluble fraction, the 
remainder occurring in the residue. On disc electro- 
phoresis, the same LP components were found in the 
water lysate as were demonstrated in Triton X-100 
extracts. These findings indicate that the soluble pro- 
tein originates primarily from the internal matrix of 
CC, the insoluble residue representing mainly mem- 
branous envelopes of CG. Moreover, sonication in 
0.2% Triton X-100 seems to cause no qualitative changes 
in the soluble LPs, but increases their yield in the soluble 
fraction. 
It is clear from these experiments that the bulk of 
the soluble protein from bovine CG consists of acidic 
I&. Our results are at variance with a recent report 
by Winkler et al. [21] in which most of the phospho- 
lipid and cholesterol of bovine CG was present in the 
insoluble residue. The method of lysis used by these 
workers, repeated freeze-thawing of CG in a tris-sodium 
succinate buffer, pH 5.9 and / 0.015, may have caused 
a dissociation of lipid and protein moieties of the sol- 
uble LPs. In this regard it is pertinent to note that 
DL-lysine (10 mM) caused a dissociation of the phos- 
pholipid from the protein in lysates of CG [lo] . 
It has been suggested that the acidic proteins or 
chromogranins may serve to provide binding sites for 
storage of the catecholamines [l-4] . The lipoprotein 
nature of the ~hromogranins may increase their bind- 
ing and storage capacity for the catecholamines. Dur- 
ing perfusion of adrenal glands in vitro, granule pro- 
teins are released into the perfusate in response to 
stimulation by secretagogues, together with ATP 
and catecholamines, without a ~on~olnitant efflux 
of phospholipid or cholesterol [22, 231. Instead, these 
lipids are retained in the adrenomedullary cells in 
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Fig. 1. Densitometer scans and disc gel electrophoretograms of 
soluble lipoprotein fractions from bovine chromaffii granules. 
A) Total soluble fraction; B) LDLP; C) HDLP; D) VHDLP. 
Asterisk in C) indicates band 8. 
granu!,-- with a reduced specific gravity [24]. These 
findings suggest hat the LPs may undergo delipida- 
tion during the sectory process. It is interesting to 
note in this context that a number of lysosomal hy- 
drolases are secreted from the adrenal gland coinci- 
dent with the secretion of catecholamines, ATP, and 
chromogranins [25]. 
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